HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

France Microbial Transglutaminase Market Size & Outlook, 2025-2033


France Microbial Transglutaminase Market Insights

  • As highlighted in Reed Intelligence analysis, the France Microbial Transglutaminase Market, worth USD 4.53 Million in 2024, is forecasted to achieve USD 10.41 Million by 2033.
  • The France market is anticipated to grow at a CAGR of 9.71% during the period 2026–2033.
  • By 2024, Streptomyces Mobaraense represented the largest share of the By Source market size.
  • Others is expected to remain the key growth driver within By Source, registering the fastest CAGR during the forecast period.

Other Key Findings


  • France contributed 3.32% to the global Microbial Transglutaminase Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Microbial Transglutaminase Market.
  • In Europe, Germany is projected to capture the leading share of market size by 2033.
  • Among Europe markets, Nordic is expected to post the fastest growth, reaching USD 3.57 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 4.53 Million
Market Size In 2033 USD 10.41 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.71% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports